Aug 10, 2021 / 10:00PM GMT
Unidentified Analyst -
Well, we have 10x here and happy to be hosting 10x on our second panel and go ahead and get started. Today, from 10x, we have Serge Saxonov, CEO; and Justin McAnear, the CFO. Welcome.
And just a reminder, if you would like to ask a question in the audience, we have instructions on the screen there, and there are also instructions on the tables.
Questions and Answers:
Unidentified Analyst -So maybe just to get started here, maybe focusing a little on the 2Q results. You had pretty strong placements in the quarter following your pricing adjustment on the Chromium Controller. Can you talk a little bit about the strategy and the increase in instrument placements in the quarter?
Justin J. McAnear - 10x Genomics, Inc. - CFO
Sure. So this is Justin McAnear, CFO. We lowered the price of the Chromium Controller to $35,000 in advance of the launch of Chromium X to make sure that we had the product positioned appropriately in our new lineup of instruments. And as we noted on our Q2 call, that drove about